Introduction
============

Production and ripening of fermented products are accompanied with the high risk of contamination by foodborne spoilage and pathogenic bacteria, such as *Listeria monocytogenes*. *L. monocytogenes* can cause a serious disease called listeriosis that can lead to brain infection and death especially among pregnant women, the elderly and immunocompromised individuals ([@B49]). This infection begins with ingestion of contaminated food and one of the most critical steps in the course of the infection is the passage through the intestine barrier ([@B10]). A multi-protein complex between adjacent epithelial cells named tight junction forms selectively permeable intestinal epithelium barrier, which prevents different pathogens and toxins permeation ([@B5]). *L. monocytogenes* expresses various factors, such as invasion protein internalin A (InlA), Listeria adhesion protein (LAP) (reviewed in [@B11]), protein named InlC ([@B26]), that compromise tight junction and other cell membrane protein complexes and form cell membrane pores and protrusions that allow bacteria invasion and multiplication in the host cells. In addition to barrier formation, intestinal epithelial cells are first that sense the presence of pathogens by recognition of different pathogen-associated molecular patterns (PAMPs) with different pathogen recognition receptors (PRRs), among which the Toll-like receptors (TLRs) are best characterized ([@B60]). Ligation of these receptors initiates activation of epithelial cells to produce molecules with direct antimicrobial effects and the molecules that induce innate immune responses, which is an indispensable step in the sequence of events leading a successful clearance of the pathogen ([@B46]). One of the most important pro-inflammatory cytokines produced by intestinal epithelial cells is IL-8 responsible for the chemotactic migration and activation of different immune cells at the site of infection ([@B44]). On the other hand, intestinal epithelial cells produce transforming growth factor (TGF)-β, the molecule with prominent immunosuppressive effect ([@B50]; [@B29]) an important role in the maintenance of barrier integrity ([@B25]).

*L. monocytogenes* infection usually requires antibiotic treatment. The knowledge that excessive and improper use of antibiotics in human and veterinary medicine is closely related to the emergence of various side-effects such as antibiotic resistance and destruction of gut microbiota ([@B18]), forced search for an alternative approach for the treatment of different infections. Probiotics have been repeatedly proven to have the potential of improving host defense against pathogens ([@B16]). As bacteria of the genus *Enterococcus* are mainly ancient and highly evolved members of the different animal intestinal tract as well as plants, soil, water, and various man-made products ([@B30]) it is reasonable to expect that they have developed different mechanisms that enable them struggling for the living space. In accordance with that, some enterococci strains produce one or more broad-spectrum antimicrobial compound(s) and may affect *L. monocytogenes* growth ([@B1]). In addition to antimicrobial effects, some enterococci could compete with pathogens for cell binding sites ([@B47]). Also, enterococci are recognized by different PRRs, that could be used for immune responses modulation ([@B57]; [@B7]) and regulation of epithelial barrier function ([@B39]). In addition, enterococci are used in the fermentation of dairy and meat products contributing to the ripening and aroma development of certain cheeses or fermented sausages, often those produced in Mediterranean countries ([@B19]; [@B41]).

However, some enterococcal strains are associated with nosocomial infections, bacteremia, urinary tract infections, and endocarditis ([@B69]). Often, they can carry multiple antibiotic resistances ([@B67]; [@B2]) and virulence factors such as cytolysin (Cyl, β-hemolysin), gelatinase (GelE), hyaluronidase (HylN) ([@B12]).

As the consequence of such opposite features of different enterococcal strains, these bacteria belong to the most controversial lactic acid bacteria (LAB) ([@B21]; [@B20]). Considering that, the enterococci represent the source of various biologically active molecules that could be very useful for the resolution of different diseases, but not forgetting their controversial status, the investigation of biological effects of non-live enterococcal preparations named postbiotics, could give a solution. In that aim, we previously isolated enterococci from fermented dairy products and tested their antimicrobial potential ([@B62]). *E. faecium* BGPAS1-3 was isolated from traditional fresh soft cheese manufactured in households on a small scale in rural location surrounding Pale mountain city in Bosnia and Herzegovina and was selected for this study due to strong antilisterial effect. We showed that *E. faecium* BGPAS1-3 produces the cell wall protein with strong direct antilisterial effect. Interestingly, the similar direct antilisterial effect is retained after treatment of *E. faecium* BGPAS1-3 with high temperature (heat-killed BGPAS1-3). In addition to this direct antimicrobial effect, we showed that live and heat-killed BGPAS1-3 could prevent tight junction disruption, allows induction of *IL-8* mRNA and stimulate *TGF*-β mRNA expression in differentiated Caco-2 monolayer infected with *L. monocytogenes*.

Materials and Methods {#s1}
=====================

Bacterial Strains, Medium, and Growth Conditions
------------------------------------------------

*E. faecium* BGPAS1-3 from the laboratory collection of the Laboratory of Molecular Microbiology, Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Serbia was used in this study. *E. faecium* BGPAS1-3 was grown in M17 broth (Merck, GmbH, Darmstadt, Germany) supplemented with glucose (0.5% w/v) (GM17) at 37°C. *L. monocytogenes* ATCC 19111 was cultivated in Brain heart infusion (BHI) broth (Oxoid, Hampshire, United Kingdom) at 37°C. Corresponding agar plates were prepared by adding agar (1.7% w/v, Torlak, Belgrade, Serbia) into each broth.

Preparation of *E. faecium* BGPAS1-3 Postbiotics
------------------------------------------------

*E. faecium* BGPAS1-3 was cultured in GM17 broth (Merck) at 37°C under aerobic conditions. The supernatant (SN BGPAS1-3) of the overnight culture (ON) was collected after centrifugation of bacterial cells at 5000 rpm for 10 min, filtrated through 0.22 μm membrane filters and stored at -20°C for further analysis. In order to obtain live and heat-killed BGPAS1-3, bacterial pellet from ON cultures was washed two times with PBS and 10 times concentrated in PBS. Live BGPAS1-3 were used for the analysis of antilisterial activity and the treatment of Caco-2 cells. In order to obtain heat-killed BGPAS1-3 the part of live cells suspension was heated at temperatures of 60°C, 70, 80, 90, and 100°C for 30 min. The treatment of BGPAS1-3 with 100°C for 30 min was sufficient to kill all bacteria so we chose this treatment conditions to obtain heat-killed BGPAS1-3 postbiotic for all further experiments. Obtained heat-killed BGPAS1-3 lots were stored at -20°C for further analysis. In order to determine the number of live bacteria for heat-killed BGPAS1-3 preparation, before the high temperature treatment of bacterial PBS suspension, bacteria were plated on GM17 agar plates and enumerated after 24 h. For the analysis of antiliserial activity, all treatment (ON BGPAS1-3, live BGPAS1-3, SN BGPAS1-3, and heat-killed BGPAS1-3) were prepared from the same number of live bacteria. In all experiments with Caco-2 cells, the cells were treated with heat-killed BGPAS1-3 prepared from live bacteria at multiplicity of infection (MOI) of 10.

PCR Detection of Virulence Determinants
---------------------------------------

The total DNA of BGPAS1-3 was used in PCR to detect the presence or absence of genes for virulence determinants and genes involved in biofilm formation. The primer sequences of the target genes, the expected amplicon sizes, and annealing temperatures are given in [Table 1](#T1){ref-type="table"}.

###### 

List of the primers used in this study.

  --------------------------------------------------------------------------------------
  Genes        Primers                                 Product size   T°C    Reference
  ------------ --------------------------------------- -------------- ------ -----------
  *hylN*       5′-ACAGAAGAGCTGCAGGAAATG-3′\            276 bp         56°C   [@B65]
               5′-GACTGACGTCCAAGTTTCCAA-3′                                   

  *agg*        5′-AAGAAAAAGAAGTAGACCAAC-3′\            1553 bp        54°C   [@B13]
               5′-AAACGGCAAGACAAGTAAATA-3′                                   

  *cylA*       5′-TGGATGATAGTGATAGGAAGT-3′\            517 bp         58°C   [@B13]
               5′-TCTACAGTAAATCTTTCGTCA-3′                                   

  *esp*        5′-TTGCTAATGCTAGTCCCAGACC-3′\           933 bp         58°C   [@B13]
               5′-GCGTCAACACTTGCATTGCCGAA-3′                                 

  *efaA^fs^*   5′-GACAGACCCTCACGAATA-3′\               705 bp         56°C   [@B13]
               5′-ATGTCATCATGCTGTAGTA-3′                                     

  *efaA^fm^*   5′-AACAGATCCGCATGAATA-3′\               735 bp         56°C   [@B13]
               5′-CATTTCATCATCTGATAGTA-3′                                    

  *fsrA*       5′-ATGAGTGAACAAATGGCTATTTA-3′\          740 bp         43°C   [@B42]
               5′-CTAAGTAAGAAATAGTGCCTTGA-3                                  

  *fsrB*       5′-GGGAGCTCTGGACAAAGTATTATCTAACCG-3′\   566 bp         43°C   [@B42]
               5′-TTGGTACCCACACCATCACTGACTTTTGC-3′                           

  *fsrC*       5′-ATGATTTTGTCGTTATTAGCTACT-3′\         1343 bp        43°C   [@B42]
               5′-CATCGTTAACAACTTTTTTACTG-3′                                 

  *gelE*       5′-CGGAAGGCGTTACTGTTGAT-3′\             957 bp         46°C   [@B47]
               5′-GAGCCATGGTTTCTGGTTGT-3′                                    

  *sprE*       5′- TTGAGCTCCGTTCCTGCCGAAAGTCATTC-3′\   591 bp         58°C   [@B42]
               5′-TTGGTACCGATTGGGGAACCAGATTGACC-3′                           

                                                                             
  --------------------------------------------------------------------------------------

Antimicrobial Activity Assay
----------------------------

Efficacy of antimicrobial compounds produced by BGPAS1-3 was tested by the deferred antagonism method using indicator strain *L. monocytogenes* ATCC 19111 ([@B36]). The antilisterial effects of ON BGPAS1-3, live BGPAS1-3 cells washed with PBS three times as well as of prepared BGPAS1-3 postbiotics, supernatant (SN) BGPAS1-3 and heat-killed BGPAS1-3. To confirm the production of antimicrobial compounds of proteinaceous nature, crystals of pronase E (Sigma Chemie, GmbH, Germany) were placed close to the edge of the wells. After incubation for 24 h at 37°C a clear zone of inhibition around the well, but not near the pronase E, was taken as a positive signal for bacteriocin production.

Cell Culture and Treatments
---------------------------

Differentiated human intestinal Caco-2 cells were used as an *in vitro* model of the intestinal epithelial barrier. Caco-2 cells were grown in DMEM supplemented with 10% fetal bovine serum (FBS), 100 μg/ml streptomycin, 100 U/ml penicillin, and 2 mM L-glutamine (Gibco, Thermo Fisher Scientific, Waltham, MA, United States). The cells were maintained in 75 cm^2^ flasks at 37°C in a humidified atmosphere containing 5% CO~2~. Cells were seeded in 24-well plate (approximately 2 × 10^5^ cells/well) and incubated at 37°C. After confluency, cells were left for 21 days to allow differentiation, as previously reported ([@B51]).

To test the protective effect of live or heat-killed BGPAS1-3 against adhesion and invasion of *L. monocytogenes* ATCC 19111, both bacterial overnight cultures and previously prepared heat-killed cells were washed in PBS and resuspended in 0.5 ml DMEM in order to treat Caco-2 cells (1 × 10^6^) with BGPAS1-3 (live or heat-killed) and *L. monocytogenes* ATCC 19111 at a MOI of 10.

Three different assays were performed on differentiated Caco-2 cells: (1) for competitive assay, live or heat-killed BGPAS1-3 suspension and *L. monocytogenes* ATCC 19111 suspension was simultaneously added on differentiated Caco-2 cells, and incubated for 1 h at 37°C in a 5% CO~2~ incubator; (2) in the displacement assay, the *L. monocytogenes* ATCC 19111 was inoculated onto differentiated Caco-2 cells for 1 h, washed 3 times with PBS prior to 2 h inoculation of live or heat-killed BGPAS1-3; (3) in the exclusion assay, Caco-2 cells were treated with live or heat-killed BGPAS1-3 for 2 h, washed 3 times with PBS prior to 1 h inoculation with *L. monocytogenes* ATCC 19111.

In all assays, the cell cultures were washed three times with PBS to remove the non-adherent bacteria and then cells were detached with Trypsin-EDTA solution (Torlak, Belgrade, Serbia). The part of detached cells was used for adhesion assay of *L. monocytogenes* ATCC 19111 ([@B71]) and calculated as the % of adhesion = \[(CFU/ml a total number of counted bacteria -- CFU/ml invaded bacteria)/ CFU/ml added bacteria\] × 100. Part of the cells used for invasion analysis was incubated with gentamicin (500 μg/ml) for 30 min in order to kill extracellular adhered bacteria. Thereafter, cells were washed three times in PBS and lysed using 500 μl of cold 0.1% Triton X-100 and plated on BHI agar plates for enumeration of internalized bacteria. The % of invasion was calculated as (CFU/ml invaded bacteria/CFU/ml added bacteria) × 100. From the rest of the cells the total RNA and proteins were isolated, and stored at -80°C for quantitative real-time PCR analysis and at -20°C for Western blot analysis.

Quantitative Real-Time PCR
--------------------------

The total RNA extraction from the Caco-2 cell was performed as previously described ([@B37]) with minor modification. Briefly, the Caco-2 cells were lysed in denaturing solution. Thereafter, acid phenol (pH 4) extraction was performed followed by 2-propanol precipitation. Reverse transcription was done using 500 ng of isolated RNA as a template, according to the instructions of the enzyme manufacturer (Thermo Fisher Scientific). Random hexamers (Applied Biosystems, Foster City, CA, United States) and RiboLock RNase inhibitor (Thermo Fisher Scientific) were used in the reactions. Synthesized cDNA was amplified in 7500 real-time PCR system (Applied Biosystems) using KAPA SYBR Fast qPCR Kit (KAPA Biosystems, Wilmington, MA, United States) under the following conditions: 3 min at 95°C activation, 40 cycles of 15 s at 95°C and 60 s at 60°C. The results were normalized to endogenous control (β-*actin*) and expressed as relative target abundance using the 2^-ΔΔCt^ method. Primers used in the study are listed in [Table 2](#T2){ref-type="table"}.

###### 

List of primers used for real time PCR analysis.

  --------------------------------------------------------------
  Genes        Primers                              Reference
  ------------ ------------------------------------ ------------
  *TLR2*       5′-TGAGCTGCCCTTGCAGATAC-3′\          This study
               5′-TGCAAGCAGGATCCAAAGGA-3′           

  *TLR4*       5′-GGATTTCACACCTCCACGCA-3′\          This study
               5′-GGTCAGAGCGTGATAGCGAG-3′           

  *MyD88*      5′-CAGTTGCCGGATCTCCAAGT-3′\          This study
               5′-GTCTCCTCCACATCCTCCCT-3′           

  *IL-8*       5′-ACACAGAGCTGCAGAAATCAGG-3′\        [@B3]
               5′-GGCACAAACTTTCAGAGACAG-3′          

  *TGF*-β      5′-CCGGGTTATGCTGGTTGTACAG-3′\        [@B9]
               5′-AAGGACCTCGGCTGGAAGTGG-3′          

  *Claudin*    5′-TCACACATACCCTGTCAGGCT-3′\         [@B15]
               5′-ATGGCCTCTCTTGGCCTCCAA-3′          

  *Occludin*   5′-TCAGGGAATATCCACCTATCACTTCAG-3′\   [@B15]
               5′-CATCAGCAGCAGCCATGTACTCTTCAC-3′    

  β-*actin*    5′-TCAGTAACAGTCCGCCTAGAAGCA-3′\      [@B34]
               5′-TTGCTGACAGGATGCAGAAGGAGA-3′       

                                                    
  --------------------------------------------------------------

Western Blotting
----------------

For protein expression analysis the cells were lysed with RadioImmunoPrecipitation Assay buffer (50 mM Tris-HCl pH 7.4; 150 mM NaCl; 1% NP-40; 0.25% sodium deoxycholate) containing Protease inhibitor cocktail tablets (Roche, Basel, Switzerland) and 1 mM phenylmethylsulfonyl fluoride (Sigma-Aldrich, St. Louis, MO, United States), for 30 min on ice. The total protein concentrations were determined using the BCA protein assay kit (Thermo Fisher Scientific). Equal amounts of proteins (20 μg) were separated by 12.5% SDS-PAGE. Electrophoresed proteins were transferred from the gel to a 0.2 μm nitrocellulose membrane (GE Healthcare) using a Bio-Rad Mini *trans*-blot system (Bio-Rad, Hercules, CA, United States). Immunoblots were blocked in a 5% non-fat dry milk in TBS-Tween (50 mM Tris-HCl, pH 7.4; 150 mM NaCl, and 0.05% Tween-20) overnight at 4°C followed by 2 h incubation at room temperature with the primary antibodies anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (as a loading control; 1:1000; Beijing Dingguo Changsheng Biotechnology Co., Ltd.,) and anti-claudin (CLDN-4, 1:1000; Novus Biologicals, United States). The membranes were subsequently washed and incubated with appropriate HRP-conjugated secondary antibodies (goat anti-rabbit; 1:10,000; Thermo Fisher Scientific) for 1 h at room temperature. Proteins were detected by enhanced chemiluminescence (Immobilon Western, Merck Millipore).

Statistical Analysis
--------------------

All experiments were repeated at least three times independently, and each set of experiments was performed in triplicate. All data are presented as mean values ± standard deviation from different experiments. One-way ANOVA with the Tukey's *post hoc* test was used to compare multiple groups. Values for *p* \< 0.05 or less were considered to be statistically significant. Statistical analysis was carried out and graphs were prepared by using GraphPad Prism 5 software.

Results and Discussion
======================

The Controversial Status of the *E. faecium* BGPAS1-3 Strain
------------------------------------------------------------

Taking into account that mechanisms evolved by different strains of the highly diverse genus *Enterococcus* could be used against various medically important pathogens we previously isolated enterococci from fermented dairy products and tested their physiological properties that contribute to the technological process of fermented food production ([@B62]).

In addition to human commensal bacteria, different species of genus *Enterococcus* are well characterized as human pathogens. In order to test the safety use of BGPAS1-3 as live probiotic, the presence of genes encoding different virulence factors in the genome of BGPAS1-3 was tested ([Table 3](#T3){ref-type="table"}). Enterococci colonize the gastrointestinal tract with adhesion factors binding to mucosal and other epithelial surfaces. In addition to the colonization of commensal bacteria, the adhesion to host tissues is considered a prerequisite for the establishment of infection ([@B28]). Enterococcal surface protein (encoded by *esp*), wall adhesins (encoded by *efaA^fs^*, and *efaA^fm^*), and aggregation substance (encoded by *agg*) are involved in the pathogenesis of *E. faecium* infections ([@B13]; [@B56]). The results of this study revealed the presence of the *esp, agg, efaA^fs^*, and *efaA^fm^* genes in the genome of BGPAS1-3. Although adhesion factors are involved in pathogenesis, our previous study suggested that the presence of the *agg* and *esp* genes positively correlate with characteristics related to probiotic potential ([@B47]).

###### 

Presence of virulence genes and the genes for biofilm formation.
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The shaded areas reflect the presence of the respective genes. fsrA, response regulator; fsrB, signaling peptide; fsrC, histidine kinase; gelE, gelatinase; sprE, serine protease; esp, enterococcal surface protein; agg, aggregation substance; efaA

fs

, cell wall adhesins (endocarditis specific antigen) expressed by E. faecalis; efaA

fm

, gene coding cell wall adhesins (endocarditis specific antigen) expressed by E. faecium; hylN, hyaluronidase; cylA, cytolysin activator.

In addition, enterococci can form a biofilm that contributes to colonization and/or virulence. Biofilm is a structured and complex community of microorganisms adhering to the biotic or abiotic surface and is associated with bacterial mutual communication named quorum sensing system. We previously showed that BGPAS1-3 has no ability to form biofilm ([@B47]) and now we tested the presence of genes involved in biofilm formation. Genes coding for proteins of the quorum sensing system are located in the *fsr* (fecal streptococci regulator) locus, consisting of the *fsrA, fsrB*, and *fsrC* genes. The presence of the complete *fsr* locus, including all three genes is necessary for biofilm formation. Importantly, the strain BGPAS1-3 carries the *fsrA* and *fsrB* genes, but not the *fsrC* gene, that is in accordance with the inability of this strain to form the biofilm. In general, the *fsr* locus is located next to the genes encoding the gelatinase (*gelE*) and the serine protease (*sprE*) and regulate their expression ([@B40]; [@B23]). Bacteria that have serine protease and gelatinase activity provide nutrients by hydrolyzing different proteins like gelatin, casein, and hemoglobin ([@B28]; [@B4]) which leads to degradation of host tissue, but also have the role in biofilm formation ([@B17]). Interestingly, although we previously showed that the strain BGPAS1-3 does not exhibit gelatinase and protease activity ([@B47]), now we showed that this strain carries the *gelE* and *sprE* genes. This inconsistency between genotype and phenotype could be explained by the absence of the intact *fsrC* gene that has been characterized as a positive regulator of the *gelE* ([@B42]; [@B61]).

Further, we tested the presences of the *cylA* gene encoding CylA serine protease which is involved in processing and activation of cytolysin (also called haemolysin), a bacterial toxin with β-haemolytic properties in humans. Also the presence of *hylN* gene, encoding hyaluronidase, a degradative enzyme associated with tissue damage ([@B54]) was analyzed. Importantly, the results revealed that none of these genes was detected in the genome of the strain BGPAS1-3 and this result is in accordance with the previously shown absence of hemolytic activity of the strain after 48 h incubation on blood agar plates ([@B47]).

The concern that bacteria belonging to *Enterococcus* sp. could act as pathogens increased with the occurrence of high-level resistance to multiple antimicrobial drugs ([@B24]). Although the strain BGPAS1-3 was previously determined as antibiotic susceptible, according to the results obtained by disc diffusion method ([@B62]), and by microdilution test, according to CLSI recommendations, BGPAS1-3 showed resistance to low levels of gentamicin, streptomycin, erythromycin, and ampicillin according to EFSA guidance ([@B47]).

Taking into account that postbiotics could mimic the beneficial therapeutic effects of probiotics while avoiding the risk of administering live microorganisms expressing virulence factors, in this study the postbiotic properties of the heat-killed BGPAS1-3 were examined in comparison to live bacteria.

The Strong Antilisterial Activity of the BGPAS1-3 Strain Is Retained After High-Temperature Treatment
-----------------------------------------------------------------------------------------------------

Among the natural dairy isolates of the LAB, antibacterial mechanisms with a broad inhibitory spectrum were found in enterococci ([@B20]; [@B62]). In accordance with that, BGPAS1-3 showed antimicrobial activity against *L. monocytogenes* ATCC 19111. Since BGPAS1-3 showed strong antilisterial effect ([Figure 1](#F1){ref-type="fig"}), we further analyzed the effects of this enterococcal strain on Caco-2 cells infected with *L. monocytogenes* ATCC 19111. Considering the controversial status of enterococci, we tested the antilisterial effects of different fractions containing no BGPAS1-3 live cells such as filtrated SN (obtained by filtration with 0.22 μm membrane filters) and heat-killed BGPAS1-3 cells. Importantly, only heat-killed BGPAS1-3 retained part of the antilisterial activity as live strain pointing out that the cell wall components contribute to this effect. Importantly, we showed that the molecule with direct antilisterial effect in this fraction is protein partially resistant on high-temperature treatment. This results are in accordance with the previously published results of our group that *Lactobacillus salivarius* BGHO1 ([@B6]) and *Lactococcus lactis* subsp. *lactis* bv. diacetylactis BGBU1-4 ([@B35]) produce bacteriocin in cell-attached form that only could be separated from bacterial cells extract and not from supernatant. Proteinaceous nature of this cell-attached molecule with antilisterial effect has been confirmed by crystals of pronase E. These cell-attached bacteriocins as well as heat-killed BGPAS1-3 were shown to be thermostable and to retain antimicrobial activity over long periods of storage.

![Direct antilisterial effect of overnight culture (ON) BGPAS1-3, live BGPAS1-3 cells, supernatant (SN) BGPAS1-3 and heat-killed BGPAS1-3 of *Enterococcus faecium* BGPAS1-3 was tested. The zone of *Listeria monocytogenes* ATCC 19111 growth inhibition around the well was taken as the positive signal of antimicrobial compounds production/activity. The confirmation of the proteinaceous nature of antimicrobial compounds is seen as a detectable growth at the edge of the inhibitory zone where the dot of pronase E crystals was placed.](fmicb-10-00412-g001){#F1}

Thus, we compared the effects of this fraction with the effects of live BGPAS1-3 on antilisterial response of Caco-2 cells. In addition to the production of antimicrobial molecules, it was shown that adhesion of enterococci to intestinal epithelial cells enables their colonization on the intestinal mucosa and therefore limits the overgrowth of pathogens ([@B27]). Our previous study indicated that enterococci isolated from dairy products are able to adhere to the surface of intestinal epithelial cells ([@B47]). In this study, we showed that about 70% of applied BGPAS1-3 adheres to Caco-2 cells after 2 h of co-cultivation. These results are in accordance with the results related to the other enterococcal surface proteins, such as Esp, Agg, AggE ([@B52]; [@B55]; [@B66]), as well as di-glucosyl-di-acyl-glycerol/lipoteichoic acid (LTA) ([@B53]), which allow binding to the intestinal epithelium. Considering that, we assessed the effectiveness of live or heat-killed BGPAS1-3 on adhesion and invasion ability of *L. monocytogenes* ATCC 19111. We found that live or heat-killed BGPAS1-3 strongly inhibited adhesion of *L. monocytogenes* ATCC 19111 to differentiated Caco-2 cells during competition (35.8% ± 5.5 and 21.1% ± 4.4), exclusion (45.5% ± 8.4 and 23.7 ± 3.5), and displacement (46.4 ± 4.9 and 44.1% ± 5.2) ([Figure 2A](#F2){ref-type="fig"}). Although live and heat-killed BGPAS1-3 have shown to reduce *L. monocytogenes* ATCC 19111 adhesion, none of the fractions has the ability to reduce the invasion of *L. monocytogenes* ATCC 19111 in Caco-2 cells ([Figure 2B](#F2){ref-type="fig"}). Well-known role of heparin and heparan sulfate expressed on epithelial host cells in the binding of enterococcal di-glucosyl-di-acyl-glycerol/LTA ([@B53]) and listerial protein, ActA ([@B58]) indicates these molecules as the place of BGPAS1-3 and *L. monocytogenes* ATCC 19111 competition. These data point to the possibility that in addition to the strong direct bactericidal antilisterial effect of BGPAS1-3, a decrease in *L. monocytogenes* ATCC 19111 adhesion on Caco-2 cells could be due to the competition of bacteria and bacterial molecules/components for the same adhesion ligands. Considering these promising results on the potential protective effect of BGPAS1-3 as live probiotic as well as the heat-killed postbiotic in the case of listerial intestinal infection, it would be very interesting to test if these probiotic/postbiotic BGPAS1-3 preparation have the same effect in an animal model of listerial infection.

![The effect of live and heat-killed *Enterococcus faecium* BGPAS1-3 on **(A)** adhesion and **(B)** invasion of *Listeria monocytogenes* ATCC 19111 on differentiated Caco-2 cells were analyzed in the competitive, the displacement and the exclusion assays. Three experiments were done. One-way ANOVA with the Tukey's *post hoc* test was used to compare CFU of *L. monocytogenes* ATCC 19111 in cultures with and without BGPAS1-3. Statistical significance *p* \< 0.001 was marked as ^∗∗∗^.](fmicb-10-00412-g002){#F2}

The Effects of BGPAS1-3 on Antilisterial Response of Caco-2 Cells
-----------------------------------------------------------------

Bacterial pathogens, including *L. monocytogenes*, can disrupt the tight junction transmembrane structures and cause epithelial barrier dysfunction ([@B11]). The different tight junction proteins form multifunctional transmembrane complex involved in intestinal homeostasis ([@B70]). Claudins are the major determinant of the barrier function of tight junctions and it was shown that decrease in expression is correlated with different human diseases ([@B22]; [@B64]; [@B31]). Accordingly, we showed that *L. monocytogenes* ATCC 19111 infection of Caco-2 cells strongly decreases claudin expression at mRNA and protein level ([Figure 3](#F3){ref-type="fig"}). On the other hand, treatment of uninfected differentiated Caco-2 cells with live or heat-killed BGPAS1-3 strongly stimulated the expression of claudin. In accordance to such protective role of BGPAS1-3, there was no significant decrease in claudin expression in *L. monocytogenes* ATCC 19111-infected Caco-2 cells treated with various fractions of BGPAS1-3. Interestingly, only heat-killed BGPAS1-3 stimulated the expression of this molecule when Caco-2 cells were treated before or after *L. monocytogenes* ATCC 19111 infection. In addition to claudin we showed that heat-killed BGPAS1-3 has stimulatory effect on expression of mRNA for occludin, another important tight junction protein in Caco-2 cells ([Supplementary Figure S1](#SM1){ref-type="supplementary-material"}). At the other hand, the infection with *L. monocytogenes* ATCC 19111 showed no effect on expression of occludin mRNA in Caco-2 cells so we did not analyzed the effect of BGPAS1-3 in the infected Caco-2 cells. This effect on tight junction proteins point to the potential protective role of BGPAS1-3 probiotic/postbiotic treatment in the case of intestinal infection. In order to confirm this assumption, it is necessary to examine the impact of these treatments on intestinal barrier function by using the equipment for transepithelial electrical resistance measurement in our further research.

![The effect of *Listeria monocytogenes* ATCC 19111, live and heat-killed *Enterococcus faecium* BGPAS1-3 on *claudin* expression by differentiated Caco-2 cells was analyzed on mRNA (qPCR, graphs) and protein (the representative images of Western blot, GAPDH was used as housekeeping protein) level in the competitive, the displacement and in the exclusion assays. Three experiments were done. One-way ANOVA with the Tukey's *post hoc* test was used to compare the expression of mRNA for claudin (relative to β-*actin* as housekeeping gene) in untreated cultures with BGPAS1-3 treated and *L. monocytogenes* ATCC 19111 treated cultures, as well as in *L. monocytogenes* ATCC 19111 treated cultures with BGPAS1-3/*L. monocytogenes* ATCC 19111 treated cultures. Statistical significance *p* \< 0.001, *p* \< 0.05 was marked as ^∗∗∗^, ^∗^, respectively.](fmicb-10-00412-g003){#F3}

Although the primary function of intestinal epithelial cells is mechanical protection, these cells have an important role in the recognition of pathogen which leads to their activation and consequently to induction of an acute immune response. IL-8 secreted by several cell types, including epithelial cells, has an important role in the attraction and activation of leukocytes ([@B44]). Moreover, it has been shown that IL-8 initiates an acute inflammatory response in listeriosis ([@B45]). In accordance with that, infection of differentiated Caco-2 cells with invasive *L. monocytogenes* ATCC 19111 in our setting increased *IL-8* mRNA expression ([Figure 4A](#F4){ref-type="fig"}). On the other hand, after the exposure of differentiated uninfected Caco-2 cells to live or heat-killed BGPAS1-3, level of *IL-8* mRNA was decreased ([Figure 4A](#F4){ref-type="fig"}). Furthermore, live or heat-killed BGPAS1-3 treatments of Caco-2 cells before *L. monocytogenes* ATCC 19111 infection decreased significantly the level of *IL-8* mRNA expression in comparison to treatment with *L. monocytogenes* ATCC19111 alone. The same results were obtained when the Caco-2 cells were treated simultaneously with live or heat-killed BGPAS1-3 and *L. monocytogenes* ATCC 19111. Interestingly, when *L. monocytogenes* ATCC 19111 infected Caco-2 cells were treated thereafter with heat-killed BGPAS1-3 the level of *IL-8* mRNA induced by *L. monocytogenes* ATCC 19111 remained unchanged ([Figure 4A](#F4){ref-type="fig"}). Taking into account indispensable role of IL-8 in the effective antilisterial host response, as well as the importance of intestinal barrier integrity, this enterococcal postbiotic exhibits potential to prevent bacterial translocation and spreading of *L. monocytogenes* infection and could be considered as safe enough treatment for listeriosis.

![The effect of *Listeria monocytogenes* ATCC 19111, live and heat-killed *Enterococcus faecium* BGPAS1-3 on **(A)** *IL-8* and **(B)** *TGF*-β mRNA expression by differentiated Caco-2 cells was analyzed in the competitive, the displacement and the exclusion assays. Three experiments were done. One-way ANOVA with the Tukey's *post hoc* test was used to compare the expression of mRNA for *IL-8* and *TGF*-β (relative to β-*actin* as housekeeping gene) in untreated cultures with BGPAS1-3 treated and *L. monocytogenes* ATCC 19111 treated cultures, as well as in *L. monocytogenes* ATCC 19111 treated cultures with BGPAS1-3/*L. monocytogenes* ATCC 19111 treated cultures. Statistical significance *p* \< 0.001, *p* \< 0.005, *p* \< 0.05 was marked as ^∗∗∗^, ^∗∗^, ^∗^, respectively.](fmicb-10-00412-g004){#F4}

In addition to the important role of IL-8 in antilisterial host defense, the unrestrained inflammation could induce disruption of epithelial barrier ([@B43]). Therefore, the simultaneous activation of immunosuppressive mechanisms that control ongoing inflammation is of crucial importance for the harmless and successful pathogen elimination. In that mean, TGF-β can protect the epithelial barrier function by preventing inflammation-mediated epithelial damage and up-regulating of the tight junction protein claudin-1 ([@B48]). Also, it was shown that TGF-β pretreatment could protect T84 monolayers against barrier dysfunction induced by enterohemorrhagic *Escherichia coli* O157:H7 ([@B25]). Infection of Caco-2 cells with *L. monocytogenes* ATCC 19111 decreased *TGF*-β mRNA expression in our experiments ([Figure 4B](#F4){ref-type="fig"}). Oppositely, exposure of uninfected differentiated Caco-2 cells to live or heat-killed BGPAS1-3 elevated level of *TGF*-β mRNA expression. In accordance to that, the treatment of Caco-2 cells with heat-killed BGPAS1-3 after *L. monocytogenes* ATCC 19111 infection and with live or heat-killed BGPAS1-3 treatment before *L. monocytogenes* ATCC 19111 infection increased significantly the level of *TGF*-β mRNA expression in comparison to treatment with *L. monocytogenes* ATCC 19111 alone. Considering the important role of TGF-β in the suppression of unrestrained inflammation and in the maintenance of intestinal epithelial barrier, this effect of BGPAS1-3 postbiotic could contribute to the protection of epithelial barrier function during listeriosis.

TLR2, TLR4, and MyD88 Are Involved in Modulation of Caco-2 Functions by BGPAS1-3
--------------------------------------------------------------------------------

The fine balance of homeostasis and defense responses in intestinal tissue is regulated with simultaneous recognition of different microbial stimuli by different TLR ([@B38]). TLRs are dominantly expressed by immune cells, but also these receptors are expressed on epithelial cells and induce cell activation in a MyD88-dependent or independent manner. Recognition of *L. monocytogenes* peptidoglycans by TLR2 in MyD88-dependent fashion was shown to be required for induction of innate immune response against this pathogen in mice model of infection ([@B63]). In addition to this, it is hypothesized that TLR4 might have a role in recognizing surface LTA of live *L. monocytogenes* in the MyD88-independent way ([@B14]). In accordance to such primary role of TLRs, it was shown that manipulation of TLR expression by probiotic strains could modulate the immune response in different diseases ([@B8]; [@B68]; [@B33]). As we expected, in our study infection of differentiated epithelial cells with *L. monocytogenes* ATCC 19111 stimulated *TLR2* mRNA expression ([Figure 5A](#F5){ref-type="fig"}). In addition to *L. monocytogenes*, the immune response to *E. faecium* was shown to be dependent on TLR2 activation ([@B32]). Interestingly, only heat-killed BGPAS1-3 stimulated expression of this receptor in Caco-2 cells. As a result, the level of *TLR2* mRNA expression was decreased in all treatments, except the unchanged level of this mRNA in the Caco-2 cells treated with heat-killed BGPAS1-3 after *L. monocytogenes* ATCC 19111 infection. On the other hand, infection of Caco-2 cells with *L. monocytogenes* ATCC 19111 suppressed the *TLR4* mRNA expression. Interestingly, although the treatment of Caco-2 with live or heat-killed BGPAS1-3 alone stimulated the level of *TLR4* mRNA expression, the expression of this receptor increased only in Caco-2 cells treated with live BGPAS1-3 after *L. monocytogenes* ATCC 19111 infection or with heat-killed BGPAS1-3 before *L. monocytogenes* ATCC 19111 infection ([Figure 5B](#F5){ref-type="fig"}). In addition, the pattern of changes in *MyD88* mRNA expression showed a strong correlation with the changes of expression of mRNA for TLRs in cultures ([Figure 5C](#F5){ref-type="fig"}). Thus, stimulation of *TLR2* and suppression of *TLR4* mRNA expression in Caco-2 by *L. monocytogenes* ATCC 19111 infection resulted in an unchanged level of *MyD88* mRNA in comparison to control Caco-2. The stimulation of *MyD88* mRNA expression in Caco-2 treated with BGPAS1-3 was consistent with the stimulation of TLR2 and TLR4 in these cultures. In accordance, expression of *Myd88* mRNA increased significantly with stimulation of both TLRs mRNA expression in Caco-2 cells treated with heat-killed BGPAS1-3 after *L. monocytogenes* ATCC 19111 infection. In addition, stimulation of the only TLR4 in Caco-2 cells treated with live BGPAS1-3 before *L. monocytogenes* ATCC 19111 infection are correlated with the increase in *MyD88* mRNA expression. More pronounced effect of heat-killed BGPAS1-3 in comparison to live bacteria is probably the result of the temperature-induced liberation of different active molecules originating inside live bacteria or sheltered in 3D structures of complex molecules on the bacterial surface. Another research group ([@B59]) previously described similar mechanisms.

![The effect of *Listeria monocytogenes* ATCC 19111, live and heat-killed *Enterococcus faecium* BGPAS1-3 on **(A)** *TLR2*, **(B)** *TLR4*, and **(C)** *MyD88* mRNA expression by differentiated Caco-2 cells was analyzed in: the competitive, the displacement and the exclusion assays. Three experiments were done. One-way ANOVA with the Tukey's *post hoc* test was used to compare the expression of mRNA for *TLR2, TLR4*, and *MyD88* (relative to β-*actin* as housekeeping gene) in untreated cultures with BGPAS1-3 treated and *L. monocytogenes* ATCC 19111 treated cultures, as well as in *L. monocytogenes* ATCC 19111 treated cultures with BGPAS1-3/*L. monocytogenes* ATCC 19111 treated cultures. Statistical significance *p* \< 0.001, *p* \< 0.005, *p* \< 0.05 was marked as ^∗∗∗^, ^∗∗^, ^∗^ respectively.](fmicb-10-00412-g005){#F5}

Conclusion
==========

Considering that heat-killed BGPAS1-3 possess strong direct antilisterial effect, simultaneously allowing the induction of immune mechanisms important for antilisterial host response and stimulates the production of protective TGF-β in intestinal epithelial cells, we assume that the application of this enterococcal postbiotic in the case of listerial infection could significantly contribute to *L. monocytogenes* clearance with minimum harmful effects on host organism. In addition to soluble bacterial products, heat-killed bacteria could be considered as postbiotic that could be used as a more controllable and safer therapeutics.
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